Sai Parenteral's Ltd IPO Synopsis

An Initial Public Offering is an opportunity for investors to take part in the growth of a company. It is always better to be in the first batch of investors. The shares offered by the company get listed on the stock exchanges and can be bought and sold by investors.

Sai Parenteral's Ltd IPO
Registered Office: No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli , Rangareddy - 500032 , Telangana , India. Phone : +91 79979 91301 Fax: Email : cs@saiparenterals.com Website : https://www.saiparenterals.com
Initial public offer of up to 10428288 equity shares of face value of (Rs)5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of (Rs)392 per equity share (Including a Share Premium of (Rs)387 Per Equity Share) ("Offer Price") aggregating up to (Rs)408.79 Crore comprising a fresh issue of up to 7270408 equity shares of face value of (Rs)5 each aggregating up to (Rs)285 Crore by the company ("Fresh Issue") and an offer for sale of up to 3,157,880 equity shares of face value of (Rs)5 each aggregating up to (Rs)123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company. Price Band: (Rs)392 per equity share of face value of (Rs)5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of (Rs)5 each and in multiples of 38 equity shares of face value of (Rs)5 each thereafter.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
24-Mar-26	27-Mar-26	(Rs)392.00-0.00	(Rs)0.00-0.00
Minimum Application for shares in Nos :38 Further Multiples of :38

(Rs Cr)

Lead Managers to the Issue

Project Cost

0.00

Arihant Capital Markets Limited

Project Financed through Current Offer

408.79

Post Issue Equity Share Capital

23.67

Issue Price

(Rs)392.00

Projects

Capacity expansion and upgradation of manufacturing facilities	Working capital requirements
Establishment of a new R&D Centre	Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
Repayment / prepayment of certain outstanding borrowings	General corporate purposes

Promoted By
Anil Kumar Karusala
Vijitha Gorrepati
Karusala Aruna

Listing At
BSE
NSE

Registrar to the Issue

Bigshare Services Pvt Ltd